EMBREX INC/NC
10-Q, EX-27, 2000-11-09
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: EMBREX INC/NC, 10-Q, EX-3, 2000-11-09
Next: MANOR CARE INC, 10-Q, 2000-11-09



<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           2,006
<SECURITIES>                                         0
<RECEIVABLES>                                    5,421
<ALLOWANCES>                                         0
<INVENTORY>                                      2,051
<CURRENT-ASSETS>                                 1,994
<PP&E>                                          40,410
<DEPRECIATION>                                  25,521
<TOTAL-ASSETS>                                  26,361
<CURRENT-LIABILITIES>                            5,070
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            87
<OTHER-SE>                                      21,149
<TOTAL-LIABILITY-AND-EQUITY>                    26,361
<SALES>                                          9,727
<TOTAL-REVENUES>                                 9,727
<CGS>                                          (4,222)
<TOTAL-COSTS>                                  (4,222)
<OTHER-EXPENSES>                               (3,352)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (28)
<INCOME-PRETAX>                                  2,147
<INCOME-TAX>                                     (185)
<INCOME-CONTINUING>                              1,962
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,962
<EPS-BASIC>                                       0.25
<EPS-DILUTED>                                     0.23



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission